Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 793 of 1,261

  1. US 8834840

    Magnetic resonance imaging of self-assembled biomaterial scaffolds

    Northwestern University · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  2. US 8834921

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  3. US 8834896

    Vault compositions for immunization

    The Regents of the University of California · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  4. US 8834854

    Oral treatment compositions and related methods of manufacture

    Ranir, LLC · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted

  5. CA 2903132

    CABAZITAXEL ET SON UTILISATION POUR LE TRAITEMENT DES CANCERS DE LA PROSTATE METASTATIQUES

    AVENTIS PHARMA SA [FR] · Granted Sep 12, 2014 · Expires Sep 7, 2034

    granted

  6. US 8829189

    Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

    TAKEDA GMBH · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  7. US 8828980

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  8. US 8828956

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Alnylam Pharmaceuticals, Inc. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  9. US 8829054

    Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container

    Welgrace Research Group · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  10. US 8829024

    Combination steroid and glucocorticoid receptor antagonist therapy

    Corcept Therapeutics Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  11. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  12. US 8828977

    Method of treating a subject suffering from degenerative disc disease using a matrix metalloprotease inhibitor

    Discogen, LLC · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  13. US 8829008

    Organic compounds

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  14. US 8829022

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  15. US 8829043

    Oligome-cannabinoid conjugates

    Nektar Therapeutics · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  16. US 8829025

    Anti-cancer compounds

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  17. US 8829030

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  18. US 8829187

    Chiral pyrrolidine core compounds en route to inhibitors of nitric oxide synthase

    Northwestern University · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  19. US 8829204

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  20. US 8829174

    HCV vaccines and methods for using the same

    Inovio Pharmaceuticals, Inc. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  21. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  22. US 8828429

    Release-control composition

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  23. US 8828717

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  24. US 8828996

    Morpholine-spirocyclic piperidine amides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.